These data add to the aforementioned studies demonstrating potent anti-viral effects of IFN-β applied before or early in the infection course and suggest that a prolonged or exaggerated type I IFN response at later stages, when virus is virtually cleared from the lungs, might be an important amplifier of a detrimental inflammatory response in IV pneumonia. This evidence concerns the gene IFNB1 and pneumonia.